What is letrozole 2.5 mg used for?
Letrozole 2.5 mg (a nonsteroidal aromatase inhibitor) is used to treat certain types of hormone-receptor–positive breast cancer, including:
- Early-stage breast cancer (in postmenopausal patients) as adjuvant therapy to help reduce the chance of the cancer coming back.
- Advanced or metastatic hormone-receptor–positive breast cancer in postmenopausal patients, including when the cancer has progressed.
- Sometimes, it’s also used in combination with other cancer treatments depending on the specific diagnosis and regimen.
How does letrozole work in the body?
Letrozole lowers estrogen levels by blocking the aromatase enzyme, which the body uses to make estrogen. This matters because many breast cancers grow in response to estrogen. By reducing estrogen, letrozole helps slow tumor growth and lowers recurrence risk.
Who can take letrozole 2.5 mg?
Letrozole 2.5 mg is primarily used in postmenopausal people with hormone-receptor–positive breast cancer. Use in other groups depends on the clinical situation and specialist guidance.
How is it usually taken?
Common regimens are once daily dosing, but the exact schedule depends on the cancer stage and treatment plan your clinician prescribes. Follow the directions on your prescription label.
What do patients commonly ask about (side effects and safety)?
Common side effects can include joint or muscle pain, hot flashes, fatigue, and headaches. Long-term estrogen suppression can also affect bone health, so clinicians often monitor bone density and may recommend calcium/vitamin D and/or bone-strengthening treatment.
If you’re asking about letrozole for a specific reason (breast cancer type, early vs metastatic, or whether you’re postmenopausal), tell me that context and I can narrow down the most likely use and what monitoring is typically done.